首页> 外文期刊>Nature reviews. Urology >Intravesical treatments of bladder pain syndrome/interstitial cystitis
【24h】

Intravesical treatments of bladder pain syndrome/interstitial cystitis

机译:膀胱疼痛综合征/间质性膀胱炎的膀胱内治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Bladder pain syndrome/interstitial cystitis (BPS/IC) is a disabling chronic condition that affects up to 7% of women in the USA. In men, BPS/IC seems to be less common, but might be underestimated because it can be confused with chronic prostatitis. The aetiology and pathophysiology of BPS/IC are not well understood. Consequently, diagnosis and treatment is challenging and most therapies used to date are off-label. These therapies include bladder instillation with dimethyl sulfoxide (DMSO) and BCG, as well as hyperbaric oxygen therapy. Overall, botulinum neurotoxin A injection, intravesical sodium hyaluronate instillation and DMSO instillation seem to be the best-performing treatments, with response rates of 79%, 76% and 75%, respectively, and can be used effectively as second-line or third-line therapies for BPS/IC. However, additional high-quality randomized controlled trials are necessary to improve the available data.
机译:膀胱疼痛综合征/间质性膀胱炎(BPS / IC)是一种致残的慢性疾病,在美国影响高达7%的女性。在男性中,BPS / IC似乎不太常见,但可能会被低估,因为它可能与慢性前列腺炎相混淆。 BPS / IC的病因和病理生理学还不清楚。因此,诊断和治疗具有挑战性,并且迄今为止使用的大多数疗法均不在标签上。这些疗法包括用二甲亚砜(DMSO)和BCG进行膀胱滴注,以及高压氧疗法。总体而言,肉毒杆菌神经毒素A注射,膀胱内透明质酸钠滴注和DMSO滴注似乎是效果最好的治疗方法,其缓解率分别为79%,76%和75%,可有效用作二线或三线治疗。 BPS / IC的线疗法。但是,需要其他高质量的随机对照试验来改善可用数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号